Best Vitelliform Macular Dystrophy
📧 Sign up to get email alerts when something new happens for Best Vitelliform Macular Dystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB) [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and tolerability of subretinally injected OPGx-BEST1 in patients with Best vitelliform macular dystrophy o…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Radiomic Analysis in OCT Imaging of Acquired Vitelliform Lesions.
A Federico II University–led study completed a radiomic analysis of OCT imaging in acquired vitelliform lesions.
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
EyeGENE Stage 3 expansion to broaden DNA and data repositories for rare inherited ophthalmic diseases; study currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Study of BEST1 Vitelliform Macular Dystrophy
Clinical trial update announcing recruitment for BEST1-related vitelliform macular dystrophy study sponsored by Columbia University.